Molecules/CATUMAXOMAB

CATUMAXOMAB

Molecular Identity

AntibodyApprovedFirst approved 2009

Mechanism of action: T cell surface glycoprotein CD3 cross-linking agent

Molecular Formula

0.00

Molecular Weight

g/mol

CATUMAXOMABREMOVAB

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to CATUMAXOMAB

Loading drug network...